Hrustanovic Gorjan 4
4 · Kymera Therapeutics, Inc. · Filed Jun 20, 2023
Insider Transaction Report
Form 4
Hrustanovic Gorjan
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-15+12,000→ 12,000 totalExercise: $27.67Exp: 2033-06-14→ Common Stock (12,000 underlying)
Footnotes (2)
- [F1]The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 15, 2024 and (ii) the date of the next annual meeting of the Issuer's stockholders.
- [F2]The Reporting Person is a member of BVF Partners L.P. ("BVF") and is obligated to transfer the economic benefit, if any, received upon the sale of the shares issuable upon exercise of the equity grants to BVF. As such, the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.